Amedeo's Top 20

Amedeo Smart

Independent Medical Education

21 November 2019

Multidisciplinary Journal Club

  1. Chung KK, Altmann D, Barkhof F, Miszkiel K, et al.
    A thirty year clinical and MRI observational study of multiple sclerosis and clinically isolated syndromes.
    Ann Neurol 2019.

  1. Seung KJ, Khan P, Franke MF, Ahmed S, et al.
    Culture conversion at six months in patients receiving delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
    Clin Infect Dis 2019.

  2. Hosomi Y, Morita S, Sugawara S, Kato T, et al.
    Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
    J Clin Oncol 2019.

  3. Gralow JR, Barlow WE, Paterson AHG, Miao JL, et al.
    Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307.
    J Natl Cancer Inst 2019.

  4. Noseworthy PA, Kaufman ES, Chen LY, Chung MK, et al.
    Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association.
    Circulation 2019.

  1. Biswal S, Reynales H, Saez-Llorens X, Lopez P, et al.
    Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
    N Engl J Med 2019.

  2. Meyers T, Samson P, Acosta EP, Moye J, et al.
    Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
    AIDS 2019;33:2197-2203.

  3. Jamil HA, Mohammed SA, Gierula J, Paton MF, et al.
    Prognostic Significance of Incidental Nonsustained Ventricular Tachycardia Detected on Pacemaker Interrogation.
    Am J Cardiol 2019;123:409-413.

  4. Castellana M, Castellana C, Treglia G, Giorgino F, et al.
    Performance of five ultrasound risk stratification systems in selecting thyroid nodules for FNA. A meta-analysis.
    J Clin Endocrinol Metab 2019.

  5. Sehn LH, Herrera AF, Flowers CR, Kamdar MK, et al.
    Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
    J Clin Oncol 2019.

  1. Rodriguez-Gutierrez R, Gonzalez-Gonzalez JG, Zuniga-Hernandez JA, McCoy RG, et al.
    Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    BMJ 2019;367:l5887.

  2. Harriott AM, Karakaya F, Ayata C.
    Headache after ischemic stroke: A systematic review and meta-analysis.
    Neurology 2019.

  3. Gonzales KM, Stan MN, Morris JC 3rd, Bernet V, et al.
    The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic.
    Thyroid 2019.

  4. Pellegrini F, Copetti M, Sormani MP, Bovis F, et al.
    Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling.
    Mult Scler 2019.

  5. Kapustin D, Bhatia A, McParland A, Trivedi A, et al.
    Evaluating the impact of gabapentinoids on sleep health in patients with chronic neuropathic pain: a systematic review and meta-analysis.
    Pain 2019.

  1. Milo R, Korczyn AD, Manouchehri N, Stuve O, et al.
    The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis.
    Mult Scler 2019.

  2. Tymejczyk O, Brazier E, Wools-Kaloustian K, Davies MA, et al.
    Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa.
    J Infect Dis 2019.

  3. Fermont JM, Masconi KL, Jensen MT, Ferrari R, et al.
    Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.
    Thorax 2019;74:439-446.

  4. Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, et al.
    Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
    J Infect Dis 2019.

  5. Bodor JN, Boumber Y, Borghaei H.
    Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).
    Cancer 2019.


more..

Privacy Policy